Application of blood-based biomarkers of Alzheimer's disease in clinical practice: Recommendations from Taiwan Dementia Society

Blood-based biomarkers (BBM) are potentially powerful tools that assist in the biological diagnosis of Alzheimer's disease (AD) in vivo with minimal invasiveness, relatively low cost, and good accessibility. This review summarizes current evidence for using BBMs in AD, focusing on amyloid, tau, and...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Yu-Wen Cheng, Yen-Ju Lin, Yung-Shuan Lin, Wei-Pin Hong, Yi-Chun Kuan, Kuan-Yi Wu, Jung-Lung Hsu, Pei-Ning Wang, Ming-Chyi Pai, Cheng-Sheng Chen, Jong-Ling Fuh, Chaur-Jong Hu, Ming-Jang Chiu
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2024-12-01
Reeks:	Journal of the Formosan Medical Association
Onderwerpen:	Alzheimer's disease Blood-based biomarkers Diagnosis Prognosis
Online toegang:	http://www.sciencedirect.com/science/article/pii/S0929664624000512
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!